By Ellen Capon (Drug Target Review)2024-01-09T14:00:08
Anthrobots derived from human tracheal cells could perform therapeutic work without initiating an immune response.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-30T09:54:00Z
2024-01-26T13:22:42
Sponsored by bit.bio
2023-03-28T11:38:32
Sponsored by Bio-Techne
2024-03-08T10:00:25
Sponsored by Molecular Devices
2023-03-08T16:29:20
Sponsored by Bio-Techne
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
Site powered by Webvision Cloud